Abstract
Hepatocyte growth factor (HGF) regulates various physiological and developmental processes in concert with other growth factors, cytokines and hormones. We examined interactions between cell signaling events elicited by HGF and the cytokine interleukin (IL)-4, in the IL-3-dependent murine myeloid cell line 32D transfected with the human HGF receptor, c-Met. HGF was a potent mitogen in these cells, and prevented apoptosis in response to IL-3 withdrawal. IL-4 showed modest anti-apoptotic activity, but no significant mitogenic activity. IL-4 synergistically enhanced HGF-stimulated DNA synthesis, whereas only additive prevention of apoptosis was observed. IL-4 did not enhance HGF-dependent tyrosine phosphorylation of c-Met or Shc. In contrast, HGF-stimulated activation of MAP kinases was enhanced by IL-4, suggesting that the IL-4 and HGF signaling pathways converge upstream of these events. Although phosphatidylinositol 3-kinase (PI3K) inhibitors diminished HGF-induced mitogenesis, anti-apoptosis, and MAP kinase activation, IL-4 enhanced HGF signaling persisted even in the presence of these inhibitors. IL-4 enhancement of HGF signaling was partially blocked in 32D/c-Met cells treated with inhibitors of MEK1 or c-Src kinases, completely blocked by expression of a catalytically inactive mutant of Janus kinase 3 (Jak3), and increased in 32D/c-Met cells overexpressing STAT6. Our results suggest that the IL-4 and HGF pathways converge at multiple levels, and that IL-4-dependent Jak3 and STAT6 activities modulate signaling events independent of PI3K to enhance HGF-dependent mitogenesis in myeloid cells, and possibly other common cellular targets.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams DH, Harvath L, Bottaro DP, Interrante R, Catalano G, Tanaka Y, Strain A, Hubscher SG, Shaw S . 1994 Proc. Natl. Acad. Sci. USA 91: 7144–7148
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR . 1995 J. Biol. Chem. 270: 27489–27494
Balkovetz DF, Lipschutz JH . 1999 Int. Rev. Cytol. 186: 225–260
Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM, Ponzetto C . 1992 Oncogene 7: 1973–1978
Birchmeier C, Gherardi E . 1998 Trends Cell. Biol. 8: 404–410
Birchmeier W, Brinkmann V, Niemann C, Meiners S, DiCesare S, Naundorf H, Sachs M . 1997 Ciba Found Symp. 212: 230–240
Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM . 1998 Nature 391: 285–287
Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG . 1996 TIBS 21: 257–261
Borset M, Seidel C, Hjorth-Hansen H, Waage A, Sundan A . 1999 Leuk. Lymphoma 32: 249–256
Chan AML, Rubin JS, Bottaro DP, Hirschfield DW, Chedid M, Aaronson SA . 1991 Science 254: 1382–1385
Cioce V, Czaky KG, Chan AML, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS . 1996 J. Biol. Chem. 271: 13110–13115
Cosman D . 1993 Cytokine 5: 95–106
Cowley S, Paterson H, Kemp P, Marshall CJ . 1994 Cell 77: 841–852
Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP . 1999 Oncogene 18: 3399–3406
Delaney B, Koh WS, Yang KH, Strom SC, Kaminski NE . 1993 Life Sci. 53: PL89–PL93
Gandino L, Longati P, Medico E, Prat M, Comoglio PM . 1994 J. Biol. Chem. 269: 1815–1820
Gohda E, Nakamura S, Yamamoto I, Minowada J . 1995 Leuk. Lymphoma 19: 197–205
Graziani A, Gramaglia D, dalla Zonca P, Cantley LC, Comoglio PM . 1991 J. Biol. Chem. 266: 22087–22090
Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA . 1996 J. Biol. Chem. 271: 695–701
Hassuneh MR, Nagarkatti PS, Nagarkatti M . 1997 Blood 89: 610–620
Hoon DSB, Okun BE, Banez M, Irie FR, Morton DL . 1991 Cancer Res. 51: 5687–5693
Iguchi T, Sogo S, Hisha H, Taketani S, Adachi Y, Miyazaki R, Ogata H, Masuda S, Sasaki R, Ito M, Fukuhara S, Ikehara S . 1999 Stem Cells 17: 82–91
Ikehara S . 1996 Leuk. Lymphoma 20: 297–303
Ikizawa K, Kajiwara K, Koshio T, Yanagihara Y . 1994 J. Allergy Clin. Immunol. 94: 620–624
Kaplan MH, Daniel C, Schindler U, Grusby KJ . 1998 Mol. Cell. Biol. 18: 1996–
Keegan AD, Nelms K, Wang L-M, Pierce JH, Paul WE . 1994 Immunol. Today 15: 423–432
Kmiecik TE, Keller JR, Rosen E, Vande Woude GF . 1992 Blood 80: 2454–2457
Machide M, Kamitori K, Nakamura Y, Kohsaka S . 1998 J. Neurochem. 71: 592–602
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG . 1994 Science 265: 966–970
Michalopoulos GK, DeFrances MC . 1997 Science 276: 60–66
Montesano R, Soriano JV, Malinda KM, Ponce LM, Kleinman HK, Bafico A, Bottaro DP, Aaronson SA . 1998 Cell. Growth Diff. 9: 355–365
Morisaki T, Yuzuki DH, Lin RT, Foshag LJ, Morton DL, Hoon DSB . 1992 Cancer Res. 52: 6059–6065
Morisaki T, Uchiyama A, Yuzuki DH, Essner R, Morton DL, Hoon DSB . 1994 Cancer Res. 54: 1113–1118
Patel BKR, Wang L-M, Lee C-C, Taylor WG, Pierce JH, LaRochelle WJ . 1996 J. Biol. Chem. 271: 22175–22182
Paul WE . 1991 Blood 77: 1859–1870
Pierce JH, Ruggiero M, Fleming TP, Di Fiore PP, Greenberger JS, Varticovski L, Schlessinger J, Rovera G, Aaronson SA . 1988 Science 239: 628–631
Postlethwaite AE, Holness MA, Katai H, Raghow R . 1992 J. Clin. Invest. 90: 1479–1485
Postlethwaite AE, Seyer JM . 1991 J. Clin. Invest. 87: 2147–2152
Rahimi N, Tremblay E, Elliott B . 1996 J. Biol. Chem. 271: 24850–24855
Rubin JS, Bottaro DP, Aaronson SA . 1993 Biochim. Biophys. Acta. 1155: 357–371
Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS . 1997 J. Biol. Chem. 272: 9457–9463
Schwall RH, Chang LY, Kahn DW, Hillan KJ, Bauer KD, Zioncheck TF . 1996 J. Cell. Biol. 133: 709–718
Schaper F, Siewert E, Gomez-Lechon MJ, Gatsios P, Sachs M, Birchmeier W, Heinrich PC, Castell J . 1997 FEBS Lett. 405: 99–103
Soon L, Flechner L, Gutkind JS, Wang LH, Baserga R, Pierce JH, Li W . 1999 Mol. Cell. Biol. 38: 16–28
Stahl SJ, Wingfield PT, Kaufman JD, Pannell LK, Cioce V, Sakata H, Taylor WG, Rubin JS, Bottaro DP . 1997 Biochem. J. 326: 763–772
Streit AC, Stern CD . 1997 Ciba. Found. Symp. 212: 155–165
Sunitha I, Shen R, McKillop IH, Lee JH, Resau J, Avigan M . 1999 Exp. Cell. Res. 250: 86–98
Torigoe T, O'Connor R, Santoli D, Reed JC . 1992 Blood 80: 617–624
Uchiyama A, Essner R, Doi F, Nguyen T, Ramming KP, Nakamura T, Morton DL, Hoon DSB . 1996 J. Cell. Biochem. 62: 443–453
Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J . 1997 Ciba. Found. Symp. 212: 119–130
van Dijk M, Muriana FJ, van Der Hoeven PC, de Widt J, Schaap D, Moolenaar WH, van Blitterswijk WJ . 1997 Biochem. J. 323: 693–699
Wang L-M, Keegan AD, Paul WE, Heidaran MA, Gutkind JS, Pierce JH . 1992 EMBO J. 11: 4899–4908
Wang L-M, Myers Jr MG, Sun X-J, Aaronson SA, White MF, Pierce JH . 1993 Science 261: 1591–1594
Weimar IS, de Jong D, Muller EJ, Nakamura T, van Gorp JM, de Gast GC, Gerritsen WR . 1997 Blood 89: 990–1000
Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR . 1998 Exp. Hematol. 9: 885–894
Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN . 1994 Nature 370: 153–157
Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T . 1993 J. Biol. Chem. 268: 21212–21217
Yashiro M, Chung Y-S, Inoue T, Nichimura S, Matsuoka T, Fukihara T, Sowa M . 1996 Int. J. Cancer 67: 289–293
Yu CZ, Hisha H, Li Y, Lian Z, Nishino T, Toki J, Adachi Y, Inaba M, Fan TX, Jin T, Iguchi T, Sogo S, Hosaka N, Song TH, Xing J, Ikehara S . 1998 Stem Cells 16: 66–77
Zamorano J, Wang HY, Wang L-M, Pierce JH, Keegan AD . 1996 J. Immunol. 157: 4926–4934
Zarnegar R, Michalopoulos GK . 1995 J. Cell. Biol. 129: 1177–1180
Acknowledgements
We thank Drs Jacalyn Pierce, Jeffrey Rubin, William Taylor, William LaRochelle, and Yuichiro Suzuki for helpful discussions. We also thank Nelson Ellmore for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Day, R., Soon, L., Breckenridge, D. et al. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene 21, 2201–2211 (2002). https://doi.org/10.1038/sj.onc.1205289
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205289
Keywords
This article is cited by
-
Hepatocyte growth factor in lung repair and pulmonary fibrosis
Acta Pharmacologica Sinica (2011)